Related Experiment Video
Updated: Apr 10, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
The human immunodeficiency virus-reverse transcriptase inhibition activity of novel pyridine/pyridinium-type
Takumi Yasuno1, Tomoyuki Ohe1, Kyoko Takahashi1
1Department of Pharmaceutical Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan.
Abstract:
In the present study, we describe the synthesis of a novel set of pyridine/pyridinium-type fullerene derivatives. The products were assessed for human immunodeficiency virus-reverse transcriptase inhibition activities. All novel fullerene derivatives showed potent human immunodeficiency virus-reverse transcriptase inhibition without cytotoxicity.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
Retrovirus Life Cycles

